Multiple sclerosis.

Glob Adv Health Med

Alan Gaby, MD, is internationally recognized as an expert in the field of nutritional therapy. He has recently completed a 30-year project, a textbook titled Nutritional Medicine . This article is adapted from chapter 137 of the textbook with permission from www.doctorgaby.com , Concord, New Hampshire, United States; 2011.

Published: January 2013

Multiple sclerosis (MS) is a chronic progressive demyelinating disease of the central nervous system. Common manifestations include paresthesias, diplopia, loss of vision, numbness or weakness of the limbs, bowel or bladder dysfunction, spasticity, ataxia, fatigue, and mental changes. Four main patterns of MS are recognized: relapsing remitting, primary progressive, secondary progressive, and progressive relapsing. The cause of MS is unknown, although it appears to be an autoimmune disease. Much of what is known about MS has been learned from an animal model of the disease, experimental allergic encephalomyelitis.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3833582PMC
http://dx.doi.org/10.7453/gahmj.2013.2.1.009DOI Listing

Publication Analysis

Top Keywords

multiple sclerosis
8
sclerosis multiple
4
sclerosis chronic
4
progressive
4
chronic progressive
4
progressive demyelinating
4
demyelinating disease
4
disease central
4
central nervous
4
nervous system
4

Similar Publications

Introduction: The current literature on the prevalence and potential association between disease-modifying therapies (DMTs) and cancer risk in the MS population has yielded mixed findings.

Methods: This study aimed to estimate cancer prevalence and cancer risk in patients with MS (PwMS) under prolonged DMT exposure. Database search include: MEDLINE PUBMED, SCOPUS, and Google Scholar.

View Article and Find Full Text PDF

Background: Limited data are available on the global rates of paediatric multiple sclerosis. Here, we report on the estimated worldwide prevalence of paediatric MS.

Methods: We included paediatric prevalence data in 2020-2022 (Multiple Sclerosis International Federation Atlas of MS) and the prevalence of child neurologists (International Child Neurology Association).

View Article and Find Full Text PDF

Inflammation and Coagulation in Neurologic and Psychiatric Disorders.

Semin Thromb Hemost

January 2025

Department of Neurology, Sheba Medical Center, Tel Ha'Shomer, Israel.

Coagulation factors are intrinsically expressed in various brain cells, including astrocytes and microglia. Their interaction with the inflammatory system is important for the well-being of the brain, but they are also crucial in the development of many diseases in the brain such as stroke and traumatic brain injury. The cellular effects of coagulation are mediated mainly by protease-activated receptors.

View Article and Find Full Text PDF

Background: Multiple sclerosis induces locomotor impairments. The objective was to characterize the effects of Multiple Sclerosis on whole-body angular momentum control during gait initiation.

Methods: Fifteen patients with Multiple Sclerosis with Expanded Disability status scale of 2.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!